ENDRA Life Sciences (NDRA) EBIT (2016 - 2021)
Historic EBIT for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$3.1 million.
- ENDRA Life Sciences' EBIT fell 3625.0% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.5 million, marking a year-over-year increase of 3.14%. This contributed to the annual value of -$10.8 million for FY2024, which is 281.74% down from last year.
- As of Q4 2021, ENDRA Life Sciences' EBIT stood at -$3.1 million, which was down 3625.0% from -$2.7 million recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' EBIT registered a high of -$360697.0 during Q1 2017, and its lowest value of -$3.3 million during Q3 2020.
- In the last 5 years, ENDRA Life Sciences' EBIT had a median value of -$2.6 million in 2019 and averaged -$2.4 million.
- In the last 5 years, ENDRA Life Sciences' EBIT crashed by 68670.41% in 2018 and then soared by 2799.16% in 2020.
- Quarter analysis of 5 years shows ENDRA Life Sciences' EBIT stood at -$2.3 million in 2017, then grew by 12.79% to -$2.0 million in 2018, then tumbled by 56.31% to -$3.1 million in 2019, then grew by 27.99% to -$2.3 million in 2020, then crashed by 36.25% to -$3.1 million in 2021.
- Its EBIT stands at -$3.1 million for Q4 2021, versus -$2.7 million for Q3 2021 and -$3.2 million for Q2 2021.